

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcomere organization (GO:0045214) | 9.26971910 |
| 2 | actin-myosin filament sliding (GO:0033275) | 9.17038240 |
| 3 | muscle filament sliding (GO:0030049) | 9.17038240 |
| 4 | regulation of skeletal muscle contraction (GO:0014819) | 7.91186741 |
| 5 | myofibril assembly (GO:0030239) | 7.77747874 |
| 6 | cardiac myofibril assembly (GO:0055003) | 7.76134639 |
| 7 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 7.64235867 |
| 8 | actin-mediated cell contraction (GO:0070252) | 7.55936294 |
| 9 | plasma membrane repair (GO:0001778) | 7.36312265 |
| 10 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 7.28435387 |
| 11 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 6.93074135 |
| 12 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 6.73575146 |
| 13 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.62523111 |
| 14 | cardiac muscle contraction (GO:0060048) | 6.36627933 |
| 15 | striated muscle contraction (GO:0006941) | 6.04427243 |
| 16 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 5.96025801 |
| 17 | skeletal muscle contraction (GO:0003009) | 5.94494253 |
| 18 | actomyosin structure organization (GO:0031032) | 5.91516406 |
| 19 | regulation of relaxation of muscle (GO:1901077) | 5.89750619 |
| 20 | cardiac muscle cell development (GO:0055013) | 5.86506189 |
| 21 | tricarboxylic acid cycle (GO:0006099) | 5.80372061 |
| 22 | regulation of actin filament-based movement (GO:1903115) | 5.70116547 |
| 23 | actin filament-based movement (GO:0030048) | 5.69114300 |
| 24 | carnitine shuttle (GO:0006853) | 5.59887763 |
| 25 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.54470283 |
| 26 | cardiac cell development (GO:0055006) | 5.50364301 |
| 27 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.41113048 |
| 28 | regulation of cell communication by electrical coupling (GO:0010649) | 5.39069792 |
| 29 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 5.38089799 |
| 30 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 5.28048326 |
| 31 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 5.25078870 |
| 32 | adult heart development (GO:0007512) | 5.13274972 |
| 33 | ventricular cardiac muscle cell action potential (GO:0086005) | 5.11343651 |
| 34 | cardiac muscle tissue morphogenesis (GO:0055008) | 5.09996808 |
| 35 | cardiac muscle hypertrophy (GO:0003300) | 5.03179054 |
| 36 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.92164375 |
| 37 | striated muscle hypertrophy (GO:0014897) | 4.87616279 |
| 38 | skeletal muscle adaptation (GO:0043501) | 4.83984251 |
| 39 | regulation of striated muscle contraction (GO:0006942) | 4.81350035 |
| 40 | fatty acid transmembrane transport (GO:1902001) | 4.79611384 |
| 41 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.77642974 |
| 42 | creatine metabolic process (GO:0006600) | 4.75667379 |
| 43 | muscle tissue morphogenesis (GO:0060415) | 4.74270302 |
| 44 | regulation of sarcomere organization (GO:0060297) | 4.67308845 |
| 45 | heart contraction (GO:0060047) | 4.60047979 |
| 46 | heart process (GO:0003015) | 4.60047979 |
| 47 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 4.55640847 |
| 48 | regulation of cofactor metabolic process (GO:0051193) | 4.46095392 |
| 49 | regulation of coenzyme metabolic process (GO:0051196) | 4.46095392 |
| 50 | skeletal muscle fiber development (GO:0048741) | 4.43651950 |
| 51 | regulation of membrane repolarization (GO:0060306) | 4.41036166 |
| 52 | heart trabecula formation (GO:0060347) | 4.35910824 |
| 53 | muscle contraction (GO:0006936) | 4.34892237 |
| 54 | muscle hypertrophy (GO:0014896) | 4.30528980 |
| 55 | response to inactivity (GO:0014854) | 4.26448213 |
| 56 | myotube cell development (GO:0014904) | 4.17384392 |
| 57 | carnitine transmembrane transport (GO:1902603) | 4.14526317 |
| 58 | muscle atrophy (GO:0014889) | 4.13756336 |
| 59 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 4.06316364 |
| 60 | cell communication involved in cardiac conduction (GO:0086065) | 4.00190392 |
| 61 | muscle system process (GO:0003012) | 3.99736058 |
| 62 | striated muscle adaptation (GO:0014888) | 3.99029048 |
| 63 | regulation of the force of heart contraction (GO:0002026) | 3.93070697 |
| 64 | striated muscle cell development (GO:0055002) | 3.92176028 |
| 65 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.91416231 |
| 66 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.91077089 |
| 67 | skeletal muscle tissue development (GO:0007519) | 3.84860502 |
| 68 | negative regulation of protein localization to cell surface (GO:2000009) | 3.79889118 |
| 69 | carnitine transport (GO:0015879) | 3.77632507 |
| 70 | amino-acid betaine transport (GO:0015838) | 3.77632507 |
| 71 | striated muscle atrophy (GO:0014891) | 3.76941150 |
| 72 | glucan biosynthetic process (GO:0009250) | 3.76341013 |
| 73 | glycogen biosynthetic process (GO:0005978) | 3.76341013 |
| 74 | 2-oxoglutarate metabolic process (GO:0006103) | 3.72854394 |
| 75 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.70357974 |
| 76 | cardiac muscle cell action potential (GO:0086001) | 3.68523464 |
| 77 | NADH metabolic process (GO:0006734) | 3.68068507 |
| 78 | negative regulation of potassium ion transport (GO:0043267) | 3.67283508 |
| 79 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.67253812 |
| 80 | response to muscle activity (GO:0014850) | 3.65265217 |
| 81 | glycogen catabolic process (GO:0005980) | 3.64140279 |
| 82 | regulation of sulfur metabolic process (GO:0042762) | 3.64077460 |
| 83 | cellular polysaccharide catabolic process (GO:0044247) | 3.63541604 |
| 84 | muscle hypertrophy in response to stress (GO:0003299) | 3.63446005 |
| 85 | cardiac muscle adaptation (GO:0014887) | 3.63446005 |
| 86 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.63446005 |
| 87 | regulation of cardiac muscle contraction (GO:0055117) | 3.61983463 |
| 88 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.61263858 |
| 89 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.61263858 |
| 90 | muscle fiber development (GO:0048747) | 3.60251868 |
| 91 | regulation of ATPase activity (GO:0043462) | 3.60031108 |
| 92 | regulation of ATP catabolic process (GO:1903289) | 3.60031108 |
| 93 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.57051375 |
| 94 | muscle cell cellular homeostasis (GO:0046716) | 3.55021250 |
| 95 | response to epinephrine (GO:0071871) | 3.54673685 |
| 96 | positive regulation of cation channel activity (GO:2001259) | 3.54495078 |
| 97 | regulation of heart rate (GO:0002027) | 3.54166078 |
| 98 | regulation of muscle system process (GO:0090257) | 3.53777438 |
| 99 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.52307587 |
| 100 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.52307587 |
| 101 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.52223817 |
| 102 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.51633722 |
| 103 | response to caffeine (GO:0031000) | 3.51629511 |
| 104 | regulation of sequestering of triglyceride (GO:0010889) | 3.50668725 |
| 105 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.50237012 |
| 106 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.46424254 |
| 107 | skeletal muscle tissue regeneration (GO:0043403) | 3.45869702 |
| 108 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.43398932 |
| 109 | glucan catabolic process (GO:0009251) | 3.39547238 |
| 110 | muscle cell development (GO:0055001) | 3.36052496 |
| 111 | muscle adaptation (GO:0043500) | 3.33796570 |
| 112 | cell communication by electrical coupling (GO:0010644) | 3.32783584 |
| 113 | cellular response to epinephrine stimulus (GO:0071872) | 3.32644722 |
| 114 | regulation of muscle contraction (GO:0006937) | 3.32593597 |
| 115 | respiratory electron transport chain (GO:0022904) | 3.30630665 |
| 116 | cytidine metabolic process (GO:0046087) | 3.29746751 |
| 117 | cytidine catabolic process (GO:0006216) | 3.29746751 |
| 118 | cytidine deamination (GO:0009972) | 3.29746751 |
| 119 | oxidative phosphorylation (GO:0006119) | 3.29719583 |
| 120 | polysaccharide catabolic process (GO:0000272) | 3.26389845 |
| 121 | detection of calcium ion (GO:0005513) | 3.20877537 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.04634988 |
| 2 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 4.04938751 |
| 3 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 3.91502133 |
| 4 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 3.91502133 |
| 5 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.87224937 |
| 6 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.77595438 |
| 7 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.68608893 |
| 8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.66353712 |
| 9 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.35277936 |
| 10 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.31787356 |
| 11 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.02066813 |
| 12 | * MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.80961151 |
| 13 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.76902470 |
| 14 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.43261375 |
| 15 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.16899199 |
| 16 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.15909140 |
| 17 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 2.13892175 |
| 18 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.12524275 |
| 19 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.06587449 |
| 20 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.01798953 |
| 21 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.95541754 |
| 22 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.93569078 |
| 23 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.83416288 |
| 24 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.79634251 |
| 25 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.70826146 |
| 26 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.70593350 |
| 27 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.62800592 |
| 28 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.61487846 |
| 29 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.58982289 |
| 30 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.53333321 |
| 31 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.44725206 |
| 32 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.42651886 |
| 33 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.41483882 |
| 34 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.39285200 |
| 35 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.33071415 |
| 36 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.31507084 |
| 37 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.31262619 |
| 38 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.31056530 |
| 39 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.30940275 |
| 40 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.30596551 |
| 41 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.27821538 |
| 42 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.22404731 |
| 43 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.21574622 |
| 44 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.21416878 |
| 45 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.21098582 |
| 46 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.20471395 |
| 47 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.20062554 |
| 48 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.19466413 |
| 49 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.17216575 |
| 50 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.16774829 |
| 51 | VDR_22108803_ChIP-Seq_LS180_Human | 1.16311657 |
| 52 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.15672532 |
| 53 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.14718688 |
| 54 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.14232075 |
| 55 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.12667539 |
| 56 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.12395639 |
| 57 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.10433521 |
| 58 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.09522169 |
| 59 | ATF3_27146783_Chip-Seq_COLON_Human | 1.09355236 |
| 60 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.08462034 |
| 61 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.06083492 |
| 62 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.05959391 |
| 63 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.05393755 |
| 64 | GATA1_19941826_ChIP-Seq_K562_Human | 1.05176659 |
| 65 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.03989506 |
| 66 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.03735671 |
| 67 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03153689 |
| 68 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.02812668 |
| 69 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.02385361 |
| 70 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.02215730 |
| 71 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.02194081 |
| 72 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.00453615 |
| 73 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.00029931 |
| 74 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.99491032 |
| 75 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.99017885 |
| 76 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.98334063 |
| 77 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.97583072 |
| 78 | * P68_20966046_ChIP-Seq_HELA_Human | 0.97308194 |
| 79 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.96751299 |
| 80 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.95491941 |
| 81 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.94599527 |
| 82 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.94367741 |
| 83 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.94136933 |
| 84 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.94088139 |
| 85 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.93964933 |
| 86 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.93668978 |
| 87 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.92540970 |
| 88 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.92518404 |
| 89 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.92377761 |
| 90 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.91397355 |
| 91 | CJUN_26792858_Chip-Seq_BT549_Human | 0.91281921 |
| 92 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.90333881 |
| 93 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.88193395 |
| 94 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.88023926 |
| 95 | GATA2_19941826_ChIP-Seq_K562_Human | 0.87602384 |
| 96 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.87262984 |
| 97 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.87164908 |
| 98 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.86861755 |
| 99 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.86861755 |
| 100 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.86493423 |
| 101 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86347240 |
| 102 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.86346848 |
| 103 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.86272595 |
| 104 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.86025371 |
| 105 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.85766488 |
| 106 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.85408582 |
| 107 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.84934345 |
| 108 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.84674779 |
| 109 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.84570647 |
| 110 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.84132580 |
| 111 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.83921345 |
| 112 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.83892359 |
| 113 | GATA1_22025678_ChIP-Seq_K562_Human | 0.83489711 |
| 114 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.82394954 |
| 115 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.82118490 |
| 116 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.82050286 |
| 117 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.82025743 |
| 118 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.82006283 |
| 119 | SA1_27219007_Chip-Seq_Bcells_Human | 0.81663010 |
| 120 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.80727808 |
| 121 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.80118751 |
| 122 | KDM2B_26808549_Chip-Seq_K562_Human | 0.80044751 |
| 123 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.79323186 |
| 124 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.78477367 |
| 125 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.78420730 |
| 126 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.78222842 |
| 127 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.78196624 |
| 128 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.78021307 |
| 129 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.77973768 |
| 130 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.77236135 |
| 131 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.77207072 |
| 132 | * CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.77111340 |
| 133 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.76991262 |
| 134 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.76487987 |
| 135 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.76100516 |
| 136 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.74784345 |
| 137 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.74223360 |
| 138 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.73764954 |
| 139 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.73596917 |
| 140 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.72941344 |
| 141 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.72145030 |
| 142 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.72130381 |
| 143 | NFYB_21822215_ChIP-Seq_K562_Human | 0.71326837 |
| 144 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.70986124 |
| 145 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.70402466 |
| 146 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.69760126 |
| 147 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.69630130 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 6.62939298 |
| 2 | MP0003646_muscle_fatigue | 6.15526939 |
| 3 | MP0000751_myopathy | 5.66066314 |
| 4 | MP0004084_abnormal_cardiac_muscle | 4.92974411 |
| 5 | MP0000749_muscle_degeneration | 4.73555906 |
| 6 | MP0004036_abnormal_muscle_relaxation | 4.30327724 |
| 7 | MP0004215_abnormal_myocardial_fiber | 4.15883065 |
| 8 | MP0004145_abnormal_muscle_electrophysio | 3.75638998 |
| 9 | MP0005330_cardiomyopathy | 3.57514442 |
| 10 | MP0004087_abnormal_muscle_fiber | 3.35743018 |
| 11 | MP0002106_abnormal_muscle_physiology | 3.09982039 |
| 12 | MP0000750_abnormal_muscle_regeneration | 3.09010591 |
| 13 | MP0005620_abnormal_muscle_contractility | 2.88909797 |
| 14 | MP0002972_abnormal_cardiac_muscle | 2.78424093 |
| 15 | MP0000747_muscle_weakness | 2.78127024 |
| 16 | MP0004130_abnormal_muscle_cell | 2.76894928 |
| 17 | MP0002269_muscular_atrophy | 2.73058378 |
| 18 | MP0000759_abnormal_skeletal_muscle | 2.56309095 |
| 19 | MP0005369_muscle_phenotype | 2.54618502 |
| 20 | MP0003137_abnormal_impulse_conducting | 2.45490020 |
| 21 | MP0008775_abnormal_heart_ventricle | 2.40632398 |
| 22 | MP0010630_abnormal_cardiac_muscle | 2.36646871 |
| 23 | MP0005385_cardiovascular_system_phenoty | 2.26923255 |
| 24 | MP0001544_abnormal_cardiovascular_syste | 2.26923255 |
| 25 | MP0004484_altered_response_of | 2.25278537 |
| 26 | MP0006138_congestive_heart_failure | 1.98301989 |
| 27 | MP0004233_abnormal_muscle_weight | 1.97683085 |
| 28 | MP0003221_abnormal_cardiomyocyte_apopto | 1.83234434 |
| 29 | MP0003828_pulmonary_edema | 1.77984247 |
| 30 | MP0006036_abnormal_mitochondrial_physio | 1.70922240 |
| 31 | MP0004510_myositis | 1.68531703 |
| 32 | MP0004085_abnormal_heartbeat | 1.68065088 |
| 33 | MP0002332_abnormal_exercise_endurance | 1.60935022 |
| 34 | MP0003950_abnormal_plasma_membrane | 1.55974953 |
| 35 | MP0005666_abnormal_adipose_tissue | 1.51983633 |
| 36 | MP0002127_abnormal_cardiovascular_syste | 1.42627220 |
| 37 | MP0002108_abnormal_muscle_morphology | 1.26759413 |
| 38 | MP0004185_abnormal_adipocyte_glucose | 1.25630813 |
| 39 | MP0005670_abnormal_white_adipose | 1.24088906 |
| 40 | MP0000733_abnormal_muscle_development | 1.23339557 |
| 41 | MP0002234_abnormal_pharynx_morphology | 1.09917523 |
| 42 | MP0005375_adipose_tissue_phenotype | 1.09010596 |
| 43 | MP0000343_altered_response_to | 1.05774479 |
| 44 | MP0001661_extended_life_span | 1.03782644 |
| 45 | MP0000266_abnormal_heart_morphology | 1.01404493 |
| 46 | MP0003567_abnormal_fetal_cardiomyocyte | 0.98862225 |
| 47 | MP0004270_analgesia | 0.97013836 |
| 48 | MP0006035_abnormal_mitochondrial_morpho | 0.94593278 |
| 49 | MP0003705_abnormal_hypodermis_morpholog | 0.87980383 |
| 50 | MP0005266_abnormal_metabolism | 0.87320404 |
| 51 | MP0005165_increased_susceptibility_to | 0.84691455 |
| 52 | MP0000013_abnormal_adipose_tissue | 0.84396180 |
| 53 | MP0003279_aneurysm | 0.81833246 |
| 54 | MP0010368_abnormal_lymphatic_system | 0.81624830 |
| 55 | MP0002971_abnormal_brown_adipose | 0.78536042 |
| 56 | MP0005275_abnormal_skin_tensile | 0.73622437 |
| 57 | MP0003806_abnormal_nucleotide_metabolis | 0.70592686 |
| 58 | MP0002128_abnormal_blood_circulation | 0.68375561 |
| 59 | MP0000003_abnormal_adipose_tissue | 0.66887361 |
| 60 | MP0000230_abnormal_systemic_arterial | 0.65416638 |
| 61 | MP0003566_abnormal_cell_adhesion | 0.60988592 |
| 62 | MP0005623_abnormal_meninges_morphology | 0.57824975 |
| 63 | MP0004043_abnormal_pH_regulation | 0.56340669 |
| 64 | MP0008438_abnormal_cutaneous_collagen | 0.52221693 |
| 65 | MP0002909_abnormal_adrenal_gland | 0.51802416 |
| 66 | MP0005451_abnormal_body_composition | 0.50501964 |
| 67 | MP0004147_increased_porphyrin_level | 0.50271424 |
| 68 | MP0000767_abnormal_smooth_muscle | 0.49326739 |
| 69 | MP0001879_abnormal_lymphatic_vessel | 0.49300246 |
| 70 | MP0002078_abnormal_glucose_homeostasis | 0.48715420 |
| 71 | MP0008961_abnormal_basal_metabolism | 0.48657567 |
| 72 | MP0000372_irregular_coat_pigmentation | 0.45713218 |
| 73 | MP0008004_abnormal_stomach_pH | 0.44901236 |
| 74 | MP0005319_abnormal_enzyme/_coenzyme | 0.44472838 |
| 75 | MP0005187_abnormal_penis_morphology | 0.42858803 |
| 76 | MP0002822_catalepsy | 0.40996241 |
| 77 | MP0003045_fibrosis | 0.40878161 |
| 78 | MP0005334_abnormal_fat_pad | 0.36802923 |
| 79 | MP0005167_abnormal_blood-brain_barrier | 0.36517749 |
| 80 | MP0002925_abnormal_cardiovascular_devel | 0.36348985 |
| 81 | MP0003879_abnormal_hair_cell | 0.33578900 |
| 82 | MP0004272_abnormal_basement_membrane | 0.32237510 |
| 83 | MP0003948_abnormal_gas_homeostasis | 0.30832387 |
| 84 | MP0000579_abnormal_nail_morphology | 0.30205192 |
| 85 | MP0002638_abnormal_pupillary_reflex | 0.29512991 |
| 86 | MP0001784_abnormal_fluid_regulation | 0.29456144 |
| 87 | MP0001614_abnormal_blood_vessel | 0.28689212 |
| 88 | MP0005535_abnormal_body_temperature | 0.28237233 |
| 89 | MP0009115_abnormal_fat_cell | 0.26375777 |
| 90 | MP0004134_abnormal_chest_morphology | 0.26367136 |
| 91 | MP0001984_abnormal_olfaction | 0.25585605 |
| 92 | MP0005166_decreased_susceptibility_to | 0.25122587 |
| 93 | MP0001299_abnormal_eye_distance/ | 0.24563344 |
| 94 | MP0003656_abnormal_erythrocyte_physiolo | 0.24416992 |
| 95 | MP0005452_abnormal_adipose_tissue | 0.22764456 |
| 96 | MP0002118_abnormal_lipid_homeostasis | 0.22745343 |
| 97 | MP0005083_abnormal_biliary_tract | 0.22319167 |
| 98 | MP0003984_embryonic_growth_retardation | 0.22209700 |
| 99 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.22093445 |
| 100 | MP0009780_abnormal_chondrocyte_physiolo | 0.21890449 |
| 101 | MP0009840_abnormal_foam_cell | 0.21777023 |
| 102 | MP0002088_abnormal_embryonic_growth/wei | 0.21156315 |
| 103 | MP0004142_abnormal_muscle_tone | 0.21029256 |
| 104 | MP0000762_abnormal_tongue_morphology | 0.21017317 |
| 105 | MP0005332_abnormal_amino_acid | 0.20470319 |
| 106 | MP0008569_lethality_at_weaning | 0.19635999 |
| 107 | MP0009384_cardiac_valve_regurgitation | 0.19603846 |
| 108 | MP0005423_abnormal_somatic_nervous | 0.19341335 |
| 109 | MP0009672_abnormal_birth_weight | 0.18517427 |
| 110 | MP0001853_heart_inflammation | 0.18457908 |
| 111 | MP0001958_emphysema | 0.17288595 |
| 112 | MP0002896_abnormal_bone_mineralization | 0.16825859 |
| 113 | MP0002877_abnormal_melanocyte_morpholog | 0.16569202 |
| 114 | MP0001727_abnormal_embryo_implantation | 0.16395485 |
| 115 | MP0005376_homeostasis/metabolism_phenot | 0.16279478 |
| 116 | MP0002970_abnormal_white_adipose | 0.16155885 |
| 117 | MP0005386_behavior/neurological_phenoty | 0.15222688 |
| 118 | MP0004924_abnormal_behavior | 0.15222688 |
| 119 | MP0002066_abnormal_motor_capabilities/c | 0.15083060 |
| 120 | MP0002114_abnormal_axial_skeleton | 0.14568255 |
| 121 | MP0008874_decreased_physiological_sensi | 0.14418489 |
| 122 | MP0000249_abnormal_blood_vessel | 0.13935344 |
| 123 | MP0010030_abnormal_orbit_morphology | 0.13928423 |
| 124 | MP0001943_abnormal_respiration | 0.12250233 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced myalgia (HP:0003738) | 7.17506798 |
| 2 | Sudden death (HP:0001699) | 7.00068258 |
| 3 | Calf muscle hypertrophy (HP:0008981) | 6.85313025 |
| 4 | Exercise-induced muscle cramps (HP:0003710) | 6.78605144 |
| 5 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.68847668 |
| 6 | Muscle fiber splitting (HP:0003555) | 6.43499200 |
| 7 | Muscle fiber inclusion bodies (HP:0100299) | 5.97023370 |
| 8 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.76958713 |
| 9 | Ventricular tachycardia (HP:0004756) | 5.69409562 |
| 10 | Hyporeflexia of lower limbs (HP:0002600) | 5.65821043 |
| 11 | Abnormality of the calf musculature (HP:0001430) | 5.46078398 |
| 12 | Myoglobinuria (HP:0002913) | 5.12102542 |
| 13 | Type 1 muscle fiber predominance (HP:0003803) | 5.09695772 |
| 14 | Nemaline bodies (HP:0003798) | 5.05237414 |
| 15 | Subaortic stenosis (HP:0001682) | 4.91033689 |
| 16 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.91033689 |
| 17 | EMG: myopathic abnormalities (HP:0003458) | 4.88150608 |
| 18 | Increased connective tissue (HP:0009025) | 4.65443843 |
| 19 | Atrial fibrillation (HP:0005110) | 4.63682271 |
| 20 | Difficulty running (HP:0009046) | 4.63302687 |
| 21 | Lipoatrophy (HP:0100578) | 4.45518122 |
| 22 | Primary atrial arrhythmia (HP:0001692) | 4.33254129 |
| 23 | Right ventricular cardiomyopathy (HP:0011663) | 4.21237940 |
| 24 | Supraventricular tachycardia (HP:0004755) | 4.18383027 |
| 25 | Supraventricular arrhythmia (HP:0005115) | 4.10022131 |
| 26 | Rhabdomyolysis (HP:0003201) | 4.04089199 |
| 27 | Myotonia (HP:0002486) | 3.93883850 |
| 28 | Asymmetric septal hypertrophy (HP:0001670) | 3.92770019 |
| 29 | Distal arthrogryposis (HP:0005684) | 3.82829852 |
| 30 | Dilated cardiomyopathy (HP:0001644) | 3.81261210 |
| 31 | Bundle branch block (HP:0011710) | 3.79979648 |
| 32 | Syncope (HP:0001279) | 3.64428337 |
| 33 | Difficulty climbing stairs (HP:0003551) | 3.50439728 |
| 34 | Palpitations (HP:0001962) | 3.47424942 |
| 35 | Myopathic facies (HP:0002058) | 3.42552541 |
| 36 | Prolonged QT interval (HP:0001657) | 3.40899515 |
| 37 | Muscle stiffness (HP:0003552) | 3.38520888 |
| 38 | Round ear (HP:0100830) | 3.35189454 |
| 39 | Ventricular arrhythmia (HP:0004308) | 3.27559350 |
| 40 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.26414954 |
| 41 | Neck muscle weakness (HP:0000467) | 3.23714033 |
| 42 | Increased variability in muscle fiber diameter (HP:0003557) | 3.22422650 |
| 43 | Heart block (HP:0012722) | 3.14075321 |
| 44 | Areflexia of lower limbs (HP:0002522) | 3.03005006 |
| 45 | Abnormal atrioventricular conduction (HP:0005150) | 2.97986350 |
| 46 | Atrioventricular block (HP:0001678) | 2.94516759 |
| 47 | Rimmed vacuoles (HP:0003805) | 2.90596082 |
| 48 | Distal lower limb muscle weakness (HP:0009053) | 2.88804473 |
| 49 | Ventricular fibrillation (HP:0001663) | 2.82911372 |
| 50 | Ulnar deviation of the wrist (HP:0003049) | 2.78891493 |
| 51 | Limb-girdle muscle atrophy (HP:0003797) | 2.56960721 |
| 52 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.54596642 |
| 53 | EMG: neuropathic changes (HP:0003445) | 2.46012315 |
| 54 | Abnormal EKG (HP:0003115) | 2.44349879 |
| 55 | Abnormal finger flexion creases (HP:0006143) | 2.37808698 |
| 56 | Frequent falls (HP:0002359) | 2.37369148 |
| 57 | Left ventricular hypertrophy (HP:0001712) | 2.37218087 |
| 58 | Distal lower limb amyotrophy (HP:0008944) | 2.36772091 |
| 59 | Muscular dystrophy (HP:0003560) | 2.34455008 |
| 60 | Hypoplastic ischia (HP:0003175) | 2.30830131 |
| 61 | Gowers sign (HP:0003391) | 2.29571428 |
| 62 | Generalized muscle weakness (HP:0003324) | 2.27327362 |
| 63 | Testicular atrophy (HP:0000029) | 2.26833832 |
| 64 | Facial diplegia (HP:0001349) | 2.26096484 |
| 65 | Palmoplantar keratoderma (HP:0000982) | 2.24439475 |
| 66 | Calcaneovalgus deformity (HP:0001848) | 2.22991008 |
| 67 | Scapular winging (HP:0003691) | 2.21929009 |
| 68 | Ketoacidosis (HP:0001993) | 2.17539147 |
| 69 | Slender build (HP:0001533) | 2.17057862 |
| 70 | Hepatic necrosis (HP:0002605) | 2.13707385 |
| 71 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.12182062 |
| 72 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.11094086 |
| 73 | Absent phalangeal crease (HP:0006109) | 2.09487160 |
| 74 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.09484652 |
| 75 | Proximal amyotrophy (HP:0007126) | 2.09005036 |
| 76 | Abnormality of the foot musculature (HP:0001436) | 2.08329465 |
| 77 | Hyperkalemia (HP:0002153) | 2.05893567 |
| 78 | Acute necrotizing encephalopathy (HP:0006965) | 2.05390844 |
| 79 | Deformed tarsal bones (HP:0008119) | 2.04581257 |
| 80 | Fetal akinesia sequence (HP:0001989) | 2.03369956 |
| 81 | Progressive muscle weakness (HP:0003323) | 2.02241258 |
| 82 | Foot dorsiflexor weakness (HP:0009027) | 2.01578724 |
| 83 | Abnormality of the ischium (HP:0003174) | 2.00693746 |
| 84 | Waddling gait (HP:0002515) | 1.97511018 |
| 85 | Increased muscle lipid content (HP:0009058) | 1.96959490 |
| 86 | Abnormality of the neuromuscular junction (HP:0003398) | 1.94948011 |
| 87 | Fatigable weakness (HP:0003473) | 1.94948011 |
| 88 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.93663704 |
| 89 | Limb-girdle muscle weakness (HP:0003325) | 1.93289198 |
| 90 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.90922881 |
| 91 | Spinal rigidity (HP:0003306) | 1.89419077 |
| 92 | Conjunctival hamartoma (HP:0100780) | 1.88838636 |
| 93 | Bulbar palsy (HP:0001283) | 1.87790832 |
| 94 | Hepatocellular necrosis (HP:0001404) | 1.86282548 |
| 95 | Malignant hyperthermia (HP:0002047) | 1.85983761 |
| 96 | Hypoglycemic coma (HP:0001325) | 1.85857247 |
| 97 | Exercise intolerance (HP:0003546) | 1.81231745 |
| 98 | Hip contracture (HP:0003273) | 1.80942787 |
| 99 | Lower limb amyotrophy (HP:0007210) | 1.80714815 |
| 100 | Acute encephalopathy (HP:0006846) | 1.77297508 |
| 101 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.75278122 |
| 102 | Steppage gait (HP:0003376) | 1.74157935 |
| 103 | Ragged-red muscle fibers (HP:0003200) | 1.73021523 |
| 104 | Large for gestational age (HP:0001520) | 1.71927421 |
| 105 | Weak cry (HP:0001612) | 1.71698994 |
| 106 | Increased intramyocellular lipid droplets (HP:0012240) | 1.70964906 |
| 107 | Congestive heart failure (HP:0001635) | 1.70577145 |
| 108 | Dicarboxylic aciduria (HP:0003215) | 1.70568034 |
| 109 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.69870079 |
| 110 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.69870079 |
| 111 | Abnormality of the calcaneus (HP:0008364) | 1.66173179 |
| 112 | Shoulder girdle muscle weakness (HP:0003547) | 1.65984771 |
| 113 | Pelvic girdle muscle weakness (HP:0003749) | 1.65282934 |
| 114 | Nonprogressive disorder (HP:0003680) | 1.47449336 |
| 115 | Long clavicles (HP:0000890) | 1.45551473 |
| 116 | Dysmetric saccades (HP:0000641) | 1.44032889 |
| 117 | Oligomenorrhea (HP:0000876) | 1.41351440 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 6.76592967 |
| 2 | TTN | 6.44130616 |
| 3 | PHKG1 | 4.63999303 |
| 4 | PHKG2 | 4.63999303 |
| 5 | PDK3 | 3.04920699 |
| 6 | PDK4 | 3.04920699 |
| 7 | DMPK | 2.98676677 |
| 8 | LMTK2 | 2.77691876 |
| 9 | TRIB3 | 2.65725981 |
| 10 | MUSK | 2.53405986 |
| 11 | MYLK | 2.41374058 |
| 12 | PKN2 | 2.35829935 |
| 13 | NEK1 | 2.30296519 |
| 14 | BCKDK | 2.17285678 |
| 15 | PINK1 | 2.09856038 |
| 16 | PIK3CA | 2.07479401 |
| 17 | PDK2 | 1.87855254 |
| 18 | NME1 | 1.75514119 |
| 19 | PIK3CG | 1.63680305 |
| 20 | TIE1 | 1.58457244 |
| 21 | MAP2K3 | 1.52367171 |
| 22 | MAP3K7 | 1.46891910 |
| 23 | STK24 | 1.33329116 |
| 24 | MAPK12 | 1.25198946 |
| 25 | MARK1 | 1.16655589 |
| 26 | MAPKAPK3 | 1.07492439 |
| 27 | PRKD1 | 1.05469267 |
| 28 | CAMK2D | 1.00969200 |
| 29 | ILK | 0.98478780 |
| 30 | GRK7 | 0.97645844 |
| 31 | ZAK | 0.94990312 |
| 32 | LIMK1 | 0.94028141 |
| 33 | PAK3 | 0.93154211 |
| 34 | PRKAA1 | 0.89355848 |
| 35 | RIPK1 | 0.86867271 |
| 36 | PRKAA2 | 0.86734866 |
| 37 | ROCK1 | 0.84858436 |
| 38 | CCNB1 | 0.84439347 |
| 39 | MAP3K3 | 0.84244537 |
| 40 | TRPM7 | 0.81388817 |
| 41 | INSRR | 0.77906094 |
| 42 | MAP3K5 | 0.74770264 |
| 43 | EPHB1 | 0.74380484 |
| 44 | PKN1 | 0.74161707 |
| 45 | ERBB3 | 0.72630588 |
| 46 | MAPK4 | 0.64890194 |
| 47 | CDC42BPA | 0.61597877 |
| 48 | PDGFRA | 0.57312215 |
| 49 | STK4 | 0.56061569 |
| 50 | FLT3 | 0.55701728 |
| 51 | AKT2 | 0.53311190 |
| 52 | STK38L | 0.53196183 |
| 53 | NEK9 | 0.52843155 |
| 54 | EPHA3 | 0.51724083 |
| 55 | CAMK2B | 0.51563800 |
| 56 | MOS | 0.51507049 |
| 57 | MAP2K4 | 0.51339998 |
| 58 | SIK1 | 0.50571314 |
| 59 | WNK4 | 0.49861433 |
| 60 | TGFBR2 | 0.49223104 |
| 61 | ROCK2 | 0.49165842 |
| 62 | MAP2K6 | 0.47838876 |
| 63 | MAP3K6 | 0.47634673 |
| 64 | STK38 | 0.47559902 |
| 65 | CAMK4 | 0.47167071 |
| 66 | KSR2 | 0.45722146 |
| 67 | PRKACB | 0.45135039 |
| 68 | DAPK3 | 0.44430448 |
| 69 | MAP2K1 | 0.44344625 |
| 70 | DYRK1B | 0.42666537 |
| 71 | CAMK2G | 0.42253628 |
| 72 | CAMK2A | 0.41640532 |
| 73 | ICK | 0.41603740 |
| 74 | SGK2 | 0.41056836 |
| 75 | PTK6 | 0.38724498 |
| 76 | TBK1 | 0.38444082 |
| 77 | WNK1 | 0.38193942 |
| 78 | RPS6KC1 | 0.36780294 |
| 79 | RPS6KL1 | 0.36780294 |
| 80 | TAOK1 | 0.35229525 |
| 81 | KDR | 0.34792642 |
| 82 | PRKACA | 0.34284537 |
| 83 | PTK2B | 0.34158771 |
| 84 | PDPK1 | 0.33064196 |
| 85 | MAPK11 | 0.30732626 |
| 86 | MAP3K13 | 0.30002761 |
| 87 | RPS6KA6 | 0.29955898 |
| 88 | PRKACG | 0.29745697 |
| 89 | CAMK1 | 0.27464963 |
| 90 | LATS1 | 0.27174071 |
| 91 | MARK2 | 0.25905780 |
| 92 | PDK1 | 0.25080169 |
| 93 | MAPK10 | 0.24976888 |
| 94 | PRKG1 | 0.23544510 |
| 95 | PRKG2 | 0.23333300 |
| 96 | RPS6KA1 | 0.22184636 |
| 97 | MTOR | 0.22109604 |
| 98 | SGK1 | 0.21738634 |
| 99 | PRKCE | 0.21520025 |
| 100 | MAP3K11 | 0.21265415 |
| 101 | PRKCH | 0.20764093 |
| 102 | LATS2 | 0.20224369 |
| 103 | FER | 0.19582960 |
| 104 | SGK494 | 0.19217755 |
| 105 | SGK223 | 0.19217755 |
| 106 | RPS6KA3 | 0.18745270 |
| 107 | SGK3 | 0.18256837 |
| 108 | STK11 | 0.18089661 |
| 109 | MAP3K1 | 0.17361712 |
| 110 | RPS6KB1 | 0.17055709 |
| 111 | MAPK7 | 0.16674827 |
| 112 | ZAP70 | 0.15734035 |
| 113 | FGFR3 | 0.15341176 |
| 114 | RET | 0.15122572 |
| 115 | JAK1 | 0.15009291 |
| 116 | UHMK1 | 0.14914567 |
| 117 | RAF1 | 0.14410884 |
| 118 | EEF2K | 0.13993495 |
| 119 | LRRK2 | 0.13853905 |
| 120 | NLK | 0.13593117 |
| 121 | FGFR4 | 0.12903850 |
| 122 | EPHB2 | 0.12303746 |
| 123 | MAP3K10 | 0.12157534 |
| 124 | MARK3 | 0.10804059 |
| 125 | RPS6KA2 | 0.10324566 |
| 126 | PRKD3 | 0.09998117 |
| 127 | PAK6 | 0.09996981 |
| 128 | RPS6KB2 | 0.09846654 |
| 129 | TAOK2 | 0.09826484 |
| 130 | MAPK13 | 0.09307117 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.57330334 |
| 2 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.27895213 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.19119288 |
| 4 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 4.09636851 |
| 5 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 4.00662562 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.28386844 |
| 7 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.05177208 |
| 8 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.95394809 |
| 9 | Parkinsons disease_Homo sapiens_hsa05012 | 2.71269277 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.61193290 |
| 11 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.57606474 |
| 12 | Carbon metabolism_Homo sapiens_hsa01200 | 2.37845368 |
| 13 | Alzheimers disease_Homo sapiens_hsa05010 | 2.09678752 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.06200764 |
| 15 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.95368301 |
| 16 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.94750641 |
| 17 | Viral myocarditis_Homo sapiens_hsa05416 | 1.90315758 |
| 18 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.84840851 |
| 19 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.68205213 |
| 20 | Huntingtons disease_Homo sapiens_hsa05016 | 1.57152224 |
| 21 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.47598096 |
| 22 | Insulin resistance_Homo sapiens_hsa04931 | 1.35570112 |
| 23 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.34573438 |
| 24 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.31008068 |
| 25 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.30585095 |
| 26 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.24238406 |
| 27 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.21258714 |
| 28 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.18347445 |
| 29 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.15028351 |
| 30 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.07460077 |
| 31 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.02942831 |
| 32 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.02181355 |
| 33 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.97014385 |
| 34 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.95303235 |
| 35 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.94827129 |
| 36 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.92706106 |
| 37 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.91977575 |
| 38 | Focal adhesion_Homo sapiens_hsa04510 | 0.84990957 |
| 39 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.80997828 |
| 40 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.79172239 |
| 41 | Tight junction_Homo sapiens_hsa04530 | 0.78834580 |
| 42 | Galactose metabolism_Homo sapiens_hsa00052 | 0.76862167 |
| 43 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.72434741 |
| 44 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.72143994 |
| 45 | Lysine degradation_Homo sapiens_hsa00310 | 0.70452440 |
| 46 | Circadian rhythm_Homo sapiens_hsa04710 | 0.70027146 |
| 47 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.68130320 |
| 48 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.67462817 |
| 49 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.67237010 |
| 50 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.63080795 |
| 51 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.61348080 |
| 52 | Long-term potentiation_Homo sapiens_hsa04720 | 0.60918597 |
| 53 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.58982514 |
| 54 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.56377722 |
| 55 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.55487733 |
| 56 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.54654817 |
| 57 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.53316979 |
| 58 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.52202077 |
| 59 | Renin secretion_Homo sapiens_hsa04924 | 0.51876195 |
| 60 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.49731762 |
| 61 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.48901707 |
| 62 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.48443636 |
| 63 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.46789824 |
| 64 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.46501658 |
| 65 | Insulin secretion_Homo sapiens_hsa04911 | 0.43424569 |
| 66 | Adherens junction_Homo sapiens_hsa04520 | 0.43273179 |
| 67 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.40578301 |
| 68 | Amoebiasis_Homo sapiens_hsa05146 | 0.40078215 |
| 69 | Salivary secretion_Homo sapiens_hsa04970 | 0.39552922 |
| 70 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.38932154 |
| 71 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.36610430 |
| 72 | Peroxisome_Homo sapiens_hsa04146 | 0.35968548 |
| 73 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.33726286 |
| 74 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.33051423 |
| 75 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.32363504 |
| 76 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.30212295 |
| 77 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.30093634 |
| 78 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.29027775 |
| 79 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.28017920 |
| 80 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.27959134 |
| 81 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.26342705 |
| 82 | Melanogenesis_Homo sapiens_hsa04916 | 0.26211892 |
| 83 | Platelet activation_Homo sapiens_hsa04611 | 0.25731887 |
| 84 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.24989432 |
| 85 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.24332689 |
| 86 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.23149836 |
| 87 | Circadian entrainment_Homo sapiens_hsa04713 | 0.20249722 |
| 88 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.18897079 |
| 89 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.18055266 |
| 90 | Olfactory transduction_Homo sapiens_hsa04740 | 0.17868110 |
| 91 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.17549257 |
| 92 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.17117918 |
| 93 | Metabolic pathways_Homo sapiens_hsa01100 | 0.16240731 |
| 94 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.15905444 |
| 95 | Histidine metabolism_Homo sapiens_hsa00340 | 0.15478565 |
| 96 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.14884208 |
| 97 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.14046728 |
| 98 | Purine metabolism_Homo sapiens_hsa00230 | 0.13665119 |
| 99 | Long-term depression_Homo sapiens_hsa04730 | 0.12503922 |
| 100 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.12010645 |
| 101 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.10975272 |
| 102 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.10432881 |
| 103 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.10354382 |
| 104 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.09838233 |
| 105 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.09315740 |
| 106 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.08815907 |
| 107 | Gap junction_Homo sapiens_hsa04540 | 0.08667461 |
| 108 | Bile secretion_Homo sapiens_hsa04976 | 0.08547092 |
| 109 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.08066706 |
| 110 | Sulfur relay system_Homo sapiens_hsa04122 | 0.07428504 |
| 111 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.05943415 |
| 112 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.03617518 |
| 113 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.03059221 |
| 114 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.02882185 |
| 115 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.01806505 |
| 116 | ABC transporters_Homo sapiens_hsa02010 | 0.00457518 |

